Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 10-2003 | 09-2003 | 07-2003 | 06-2003 | |
| Sales | 303 | 7,972 | 194 | 7,746 | 94 |
| Cost of Goods | 278 | 5,845 | 69 | 5,550 | 37 |
| Gross Profit | 25 | 2,127 | 125 | 2,196 | 57 |
| Operating Expenses | 2,561 | 3,258 | 1,960 | 3,044 | 1,730 |
| Operating Income | -2,258 | -286 | -1,766 | -298 | -1,636 |
| Interest Expense | 70 | 43 | 84 | 53 | 82 |
| Other Income | -937 | 18 | -3,572 | -3 | -1,971 |
| Pre-tax Income | -3,265 | -311 | -5,422 | -354 | -3,689 |
| Income Tax | N/A | -10 | N/A | -12 | N/A |
| Net Income Continuous | -3,265 | -301 | -5,422 | -342 | -3,689 |
| Net Income | $-3,265 | $-301 | $-5,422 | $-342 | $-3,689 |
| EPS Basic Total Ops | -47.60 | -0.08 | -79.33 | -0.09 | -58.17 |
| EPS Basic Continuous Ops | -47.57 | -0.08 | -77.85 | -0.09 | -58.20 |
| EPS Diluted Total Ops | -47.60 | -0.08 | -79.33 | -0.09 | -58.17 |
| EPS Diluted Continuous Ops | -47.57 | -0.08 | -77.85 | -0.09 | -58.20 |
| EBITDA(a) | $1,106 | $-337 | $2,045 | $-94 | $392 |